Canakinumab in pediatric rheumatic diseases

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.13, Iss.4, 2013-04, pp. : 615-622

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Future of tissue engineering in rheumatic diseases

By Ringe Jochen Häupl Thomas Sittinger Michael

Expert Opinion on Biological Therapy, Vol. 7, Iss. 3, 2007-03 ,pp. : 283-287

Informa Healthcare

Access to resources Recommend Favorite

Canakinumab for treatment of cryopyrin-associated periodic syndrome

By Feist Eugen Burmester Gerd R

Expert Opinion on Biological Therapy, Vol. 10, Iss. 11, 2010-11 ,pp. : 1631-1636

Informa Healthcare

Access to resources Recommend Favorite

Omalizumab for pediatric asthma

By Townley Robert G Agrawal Swati Sapkota Kiran

Expert Opinion on Biological Therapy, Vol. 10, Iss. 11, 2010-11 ,pp. : 1595-1608

Informa Healthcare

Access to resources Recommend Favorite

Immune-based therapeutics for pediatric cancer

By Capitini Christian M Mackall Crystal L Wayne Alan S

Expert Opinion on Biological Therapy, Vol. 10, Iss. 2, 2010-02 ,pp. : 163-178

Informa Healthcare

Access to resources Recommend Favorite